BioTech/Drugs - Princeton, NJ, US
Longevica is a life science company researching the mechanisms of healthy aging and life extension. Our discovery of a set of compounds that showed a significant life extension effect of 16 to 22 percent led to the development of clinically-validated products and therapeutic interventions that measurably improve health and quality of life, prevent age-related disease, and facilitate a productive extension of lifespan. In 2022, we are launching an open-source platform to facilitate scientific research collaboration and breakthrough discoveries in the longevity science field and expedite consumer access to resulting novel health products. The platform will provide scientists and research institutions access to the Longevica research dataset, created over 11 years with $13M investment, and including the largest study of 1033 compounds covering the entire spectrum of modern pharmacology. Longevica's platform will also enable researchers to test drugs of their choice in our full-scale pharmacological screening experiment, to be conducted at Jackson Laboratory, a leading biomedical research institution.
Gmail
Varnish
Google Tag Manager
Mobile Friendly
Amazon AWS